Published Date: 02 Mar 2023
Experts say the ACR/AAHKS 2022 guidelines for patients undergoing total hip replacement or total knee replacement have several limitations that limit the effectiveness of their recommendations.
Read Full NewsIn a post hoc analysis of 2 phase 3 trials, AD109 reduced hypoxic burden by 69.8% vs 20.0% with placebo in postmenopausal women with OSA.
Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD
2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics
Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD
Kiril Kiprovski, MD, clinical professor of neurology and director of the Division of Neuromuscular Medicine at NYU Langone, reviews the clinical clues, bedside tests, and referral considerations that help eye care clinicians identify Lambert-Eaton myasthenic syndrome in patients with fluctuating ptosis or diplopia.
The 500-participant study will assess whether pridopidine, an investigational sigma-1 receptor agonist, can slow functional decline and improve survival in patients with early, rapidly progressing amyotrophic lateral sclerosis.
1.
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy
2.
Study sets benchmark for treatment of advanced cervical cancer
3.
According to a study, white Americans are overdiagnosing melanoma at an alarming rate.
4.
Abnormal Shadow on Chest Radiograph
5.
Is There a Role for Stimulants in Beating Cancer Fatigue?
1.
Precision Risk Interception in Oncology: A Comprehensive Review
2.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
3.
Patient Management Following Organ-Preserving Cancer Interventions
4.
Progressive Insights in Hematology in the Digital Era
5.
Prevention of Heparin-Induced Thrombocytopenia Complications Through Platelet Activation Signature Monitoring
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
2.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
4.
Recognizing Symptoms of Vitamin B12 Deficiency
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation